LifeTech Scientific (HKG:1302) Stock Falls 6.0% in Past Week as Three-year Earnings and Shareholder Returns Continue Downward Trend
LifeTech Scientific (HKG:1302) Stock Falls 6.0% in Past Week as Three-year Earnings and Shareholder Returns Continue Downward Trend
If you love investing in stocks you're bound to buy some losers. But the long term shareholders of LifeTech Scientific Corporation (HKG:1302) have had an unfortunate run in the last three years. So they might be feeling emotional about the 59% share price collapse, in that time. And more recent buyers are having a tough time too, with a drop of 36% in the last year. On top of that, the share price is down 6.0% in the last week. However, this move may have been influenced by the broader market, which fell 3.0% in that time.
如果你熱愛投資股票,你肯定會買到一些失敗的股票。但是,LifeTech Scientific Corporation(香港股票代碼:1302)的長期股東在過去三年中過得很不幸。所以他們可能會對這段期間59%的股價暴跌感到情緒低落。而且,最近的買家也面臨困難,去年股價下跌了36%。此外,上週股價也下跌了6.0%。然而,這一波動可能受到了更大市場的影響,因爲在此期間市場整體下跌了3.0%。
If the past week is anything to go by, investor sentiment for LifeTech Scientific isn't positive, so let's see if there's a mismatch between fundamentals and the share price.
如果過去一週的情況有所說明,投資者對LifeTech Scientific的情緒並不積極,所以我們來看看基本面與股價之間是否存在不匹配。
There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price.
不可否認,市場有時是有效的,但價格並不總是反映基礎業務的表現。一種有缺陷但合理的評估公司情緒變化的方法是將每股收益(EPS)與股價進行比較。
During the three years that the share price fell, LifeTech Scientific's earnings per share (EPS) dropped by 10% each year. This reduction in EPS is slower than the 26% annual reduction in the share price. So it's likely that the EPS decline has disappointed the market, leaving investors hesitant to buy.
在股價下跌的這三年中,LifeTech Scientific的每股收益(EPS)每年下降了10%。每股收益的下降速度慢於股價每年26%的下降。因此,很可能每股收益的下降讓市場失望,導致投資者對購買持謹慎態度。
The image below shows how EPS has tracked over time (if you click on the image you can see greater detail).
下圖顯示了每股收益隨着時間的變化(如果你點擊圖片,可以看到更詳細的信息)。

It might be well worthwhile taking a look at our free report on LifeTech Scientific's earnings, revenue and cash flow.
您可以免費查看LifeTech Scientific的收益、營業收入和現金流的報告,可能會有所收穫。
A Different Perspective
不同的視角
While the broader market gained around 16% in the last year, LifeTech Scientific shareholders lost 36%. However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. Longer term investors wouldn't be so upset, since they would have made 4%, each year, over five years. It could be that the recent sell-off is an opportunity, so it may be worth checking the fundamental data for signs of a long term growth trend. It's always interesting to track share price performance over the longer term. But to understand LifeTech Scientific better, we need to consider many other factors. To that end, you should be aware of the 2 warning signs we've spotted with LifeTech Scientific .
雖然整個市場在過去一年中上漲了大約16%,但生命科技的股東卻損失了36%。然而,請記住,即使是最好的股票有時在十二個月內也會表現不佳。長期投資者可能不會太沮喪,因爲他們在五年內每年獲得了4%的收益。最近的賣出可能是一個機會,因此檢查基本數據以尋找長期增長趨勢的跡象可能是值得的。跟蹤股票價格的長期表現總是很有趣。但要更好地理解生命科技,我們需要考慮許多其他因素。爲此,您應該注意我們發現的生命科技的2個警告信號。
For those who like to find winning investments this free list of undervalued companies with recent insider purchasing, could be just the ticket.
對於喜歡尋找贏家投資的人來說,這份關於最近有內部人士購買的被低估公司的免費名單,可能正是你所需要的。
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Hong Kong exchanges.
請注意,本文中引用的市場回報反映了目前在香港交易所交易的股票的市場加權平均回報。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對本文有反饋?對內容有疑慮?請直接與我們聯繫。或者,發送電子郵件至 editorial-team (at) simplywallst.com。
這篇來自Simply Wall St的文章是一般性的。我們根據歷史數據和分析師預測提供評論,採用無偏見的方法,我們的文章並不旨在提供財務建議。它不構成對任何股票的買入或賣出建議,也未考慮到您的目標或財務狀況。我們旨在爲您提供以基本數據驅動的長期分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St在提到的任何股票中均沒有持倉。